Data / Form D filings / NANOVIRICIDES, INC.
NANOVIRICIDES, INC.: Form D filings
NANOVIRICIDES, INC., a pharmaceuticals company in Shelton, CT, filed 4 Form D notices with the SEC between 2010 and 2026. The latest, on February 25, 2026, reports $6 million sold of a $6 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1 CONTROLS DRIVE, Shelton, CT, 06484
- Phone
- (203) 937-6137
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1379006
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 25, 2026 | New notice | $6,000,000 | $6,000,000 | 1 | Nov 12, 2025 | sec.gov | |
| Mar 8, 2019 | New notice | $2,500,000 | $2,500,000 | 2 | Feb 28, 2019 | sec.gov | |
| Feb 4, 2013 | New notice | $6,000,000 | $6,000,000 | 4 | Feb 1, 2013 | sec.gov | |
| Jul 26, 2010 | New notice | Indefinite | $0 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Anil Diwan | Executive Officer, Director | President, Chairman and Chief Executive Officer |
| Meeta Vyas | Executive Officer | |
| Makarand Jawadekar | Director | |
| Theodore Edward Rokita | Director | |
| Zucker Brian | Director |
Other pharmaceuticals companies in Connecticut that filed recently
- Thetis Pharmaceuticals LLC $560,300 · Oct 13, 2026
- Inventure, LLC $82,345 · Sep 3, 2026
Every Form D from the week of Feb 23, 2026 · All recent filings in Connecticut · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what NANOVIRICIDES, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.